ENZYMOTEC LTD's ticker is ENZY and the CUSIP is M4059L101. A total of 37 filers reported holding ENZYMOTEC LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $12,000 | -87.4% | 1,043 | -87.4% | 0.00% | -75.0% |
| Q3 2017 | $95,000 | +75.9% | 8,291 | +23.3% | 0.01% | +33.3% |
| Q2 2017 | $54,000 | -16.9% | 6,725 | -9.4% | 0.01% | 0.0% |
| Q1 2017 | $65,000 | +103.1% | 7,420 | +53.6% | 0.01% | +100.0% |
| Q4 2016 | $32,000 | +700.0% | 4,831 | +827.3% | 0.00% | – |
| Q3 2016 | $4,000 | +300.0% | 521 | +254.4% | 0.00% | – |
| Q4 2015 | $1,000 | -50.0% | 147 | -29.0% | 0.00% | – |
| Q3 2015 | $2,000 | +100.0% | 207 | +29.4% | 0.00% | – |
| Q4 2014 | $1,000 | 0.0% | 160 | +60.0% | 0.00% | – |
| Q3 2014 | $1,000 | -50.0% | 100 | -23.1% | 0.00% | – |
| Q2 2014 | $2,000 | -71.4% | 130 | -60.4% | 0.00% | -100.0% |
| Q1 2014 | $7,000 | 0.0% | 328 | +21.5% | 0.00% | 0.0% |
| Q4 2013 | $7,000 | – | 270 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 202,962 | $5,482,000 | 1.66% |
| Visium Asset Management, LP | 690,000 | $18,637,000 | 0.37% |
| ALYDAR PARTNERS LLC | 90,000 | $2,431,000 | 0.25% |
| Paulson & Co. | 1,733,030 | $46,809,000 | 0.23% |
| GILDER GAGNON HOWE & CO LLC | 218,232 | $5,894,000 | 0.08% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 83,971 | $2,268,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 10,000 | $270,000 | 0.04% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 5,450 | $148,000 | 0.03% |
| TFS CAPITAL LLC | 9,736 | $263,000 | 0.01% |
| BLACKROCK ADVISORS LLC | 208,806 | $5,640,000 | 0.01% |